Podcasts about tissue regeneration

I'd love to hear from you 'text the show'

Get My Book On Amazon: https://a.co/d/avbaV48Download The Peptide Cheat Sheet: https://peptidecheatsheet.carrd.co/Download The Bioregulator Cheat Sheet: https://bioregulatorcheatsheet.carrd.co/

February is American Heart Month, and in light of that, we're bringing back an episode about a group here at Stanford Engineering that's developing 3D printing methods for human tissues and organs, a process known as bioprinting. Motivated in part by the critical need for heart transplants, Mark Skylar-Scott and his team are specifically working to bioprint tissues of the human heart. It may sound like science fiction, but it's actually just another example of the groundbreaking research we do here. We hope you'll take another listen and be inspired by the possibilities.Have a question for Russ? Send it our way in writing or via voice memo, and it might be featured on an upcoming episode. Please introduce yourself, let us know where you're listening from, and share your quest. You can send questions to thefutureofeverything@stanford.edu.Episode Reference Links:Stanford Profile: Mark A. Skylar-ScottMark's Lab: The Skylar-Scott Lab | Stanford MedicineConnect With Us:Episode Transcripts >>> The Future of Everything WebsiteConnect with Russ >>> Threads / Bluesky / MastodonConnect with School of Engineering >>> Twitter/X / Instagram / LinkedIn / FacebookChapters:(00:00:00) IntroductionRuss Altman introduces guest, Mark Skylar-Scott, a professor of bioengineering at Stanford University.(00:02:06) What is Bioprinting?The role of cells and biopolymers in printing functional biological structures.(00:03:31) Bioprinting a HeartThe potential of printing organs on demand, especially heart tissue.(00:04:38) Obtaining Cells for BioprintingUsing stem cells derived from the patient's own cells to create heart tissue.(00:06:29) Creating Multiple Cell Types for the HeartThe challenge of printing eleven different heart cell types with precision.(00:08:50) The Scaffold for 3D PrintingThe support material used in 3D printing and how it's later removed.(00:10:10) Cell Migration and Organ FormationHow cells organize themselves to form functional heart tissue.(00:12:08) Growing a Full-Sized HeartWhether they're printing full-sized hearts or starting with smaller organs.(00:13:34) Avoiding Overgrowth RisksThe role of bioreactors in shaping the early stages of the organ.(00:14:57) Scaling Up Cell ProductionThe need to generate massive numbers of cells for experimentation.(00:18:32) The Challenge of VascularizationCreating a blood vessel network to supply oxygen and nutrients.(00:22:35) Ethical Considerations in BioprintingConsent, stem cell sourcing, and the broader ethical landscape.(00:26:04) The Timeline for Bioprinted OrgansThe long timeline for bioprinted organs to reach clinical use.(00:27:24) The State of the Field & CollaborationThe collaborative, competitive biofabrication field and its rapid progress.(00:28:20) Conclusion Connect With Us:Episode Transcripts >>> The Future of Everything WebsiteConnect with Russ >>> Threads / Bluesky / MastodonConnect with School of Engineering >>>Twitter/X / Instagram / LinkedIn / Facebook

Guest Kristy Red-Horse is a biologist who specializes in coronary artery development and disease. She says the latest advances in treatment of blockages could do away with invasive bypass surgeries in favor of growing new arteries using molecules like CXCL12, known to promote artery regrowth in mice. Red-Horse explains how leaps forward in medical imaging, expanding atlases of gene expressions, and new drug delivery mechanisms could someday lead to trials in humans. But, before that day can arrive, much work remains, as Red-Horse tells host Russ Altman in this episode of Stanford Engineering's The Future of Everything podcast.Have a question for Russ? Send it our way in writing or via voice memo, and it might be featured on an upcoming episode. Please introduce yourself, let us know where you're listening from, and share your quest. You can send questions to thefutureofeverything@stanford.edu.Episode Reference Links:Stanford Profile: Kristy Red-HorseKristy's Lab: Red-Horse LabConnect With Us:Episode Transcripts >>> The Future of Everything WebsiteConnect with Russ >>> Threads / Bluesky / MastodonConnect with School of Engineering >>> Twitter/X / Instagram / LinkedIn / FacebookChapters:(00:00:00) IntroductionRuss Altman introduces Kristy Red-Horse, a professor of biology at Stanford University.(00:03:46) Replacing Open-Heart SurgeryWhy bypass surgery is invasive, risky, and requires long recovery.(00:05:09) Challenges in Artery GrowthThe difficulty of targeting artery growth with medical interventions.(00:07:32) The Role of Collateral ArteriesDefinition and function of collateral arteries as natural bypass.(00:09:37) Triggers for Natural Bypass FormationGenetic factors that may influence the growth of these bypass arteries.(00:10:49) Unique Properties of Coronary ArteriesChallenges of ensuring artificial growth replicates natural artery function.(00:13:04) The Discovery of CXCL12A key molecule that stimulates collateral artery formation.(00:16:16) Precise Artery Growth ControlThe results of targeted CXCL12 injections into mice hearts.(00:17:32) CXCL12's Overlooked RoleThe molecule's role in the immune system and stem cells.(00:20:27) Guinea Pigs and Heart Attack ResistanceHow guinea pigs naturally develop collaterals.(00:23:19) Preventing Heart DiseaseUsing artery growth treatments to target early-stage coronary disease.(00:25:25) Breakthroughs in Imaging TechnologyNew technology that enables identification of collateral growth pathways.(00:27:07) How Collateral Arteries FormThe two mechanisms in which new arteries form.(00:28:48) The Future of Medical Artery GrowthThe possibility of eliminating bypass surgery with targeted artery growth. Connect With Us:Episode Transcripts >>> The Future of Everything WebsiteConnect with Russ >>> Threads / Bluesky / MastodonConnect with School of Engineering >>>Twitter/X / Instagram / LinkedIn / Facebook

For the latest episode of the Next ReGeneration podcast in 2024 hosts Anina and Elena are joined by Leonardo Trombelli. He shares his unique perspective on how periodontal treatments and implant surgery have evolved throughout the years to become less invasive for patients. Trombelli looks back on the serendipity moment when he came up with the idea of the single flap approach, that can be used to properly access many periodontal defects. He elaborates on taking advantage of the periosteum in peri-implant regenerative procedures and shares insights on how he came up with the Sub-periosteal peri-implant augmented layer (SPAL) technique to finally highlight his most recent idea of the pedicle periosteal flap. The connective tissue of Trombelli's career as a researcher and clinicians is his lifelong mission on making surgical procedures less complex and more accessible to clinicians of various skill levels, while at the same time reducing the invasiveness of the interventions for the patients.

Send us a textDiscovering new hope for hair loss! In this episode of Causes or Cures, Dr. Eeks chats with Dr. Sheila MacNeil and Dr. Muhammad Yar about their accidental discovery that a simple sugar compound may stimulate hair regrowth and help end male-pattern baldness, or androgenic alopecia—a condition affecting many people. They dive into how an unexpected finding in a study on wound healing sparked their current study on hair loss, which they break down in the episode. The researchers walk us through how the study was conducted, results, how their findings compare to current prescription treatments for hair loss, and what's next in their research.Dr. MacNeil is an Emeritus Professor of Tissue Engineering at the University of Sheffield, UK, with over 550 peer-reviewed publications in soft tissue engineering. You can learn more about Dr. MacNeil here. Dr. Yar is an Associate Professor at the Interdisciplinary Research Center for Biomedical Materials at COMSATS University in Islamabad, Pakistan. Previously, he served as an Assistant Professor at King Fahd University in Saudi Arabia. You can learn more about his work here.*New* SUBSCRIBE for Upcoming Bonus Episodes!You can contact Dr. Eeks at bloomingwellness.com.Follow Eeks on Instagram here.Or Facebook here.Or X.On Youtube.Or TikTok.SUBSCRIBE to her monthly newsletter here.Support the show

In the latest episode of the Next Regeneration podcast, hosts Anina and Elena talk to Nikos Donos, who shares his more than 20 years of experience using biologics for tissue regeneration and discusses the potential and limitations of different biologic agents. Much of his research has contributed to a better understanding of how different biological factors can enhance specific pathways in the healing cascade, and therefore the importance of using them in a biologically oriented way to maximise their efficacy. In this interview, Donos reflects on how patient selection will become increasingly important. In this respect, biologics that specifically enhance the resolution of inflammation may likely be beneficial in patients with diseases with inflammatory pathogenesis, such as diabetes. Tune in now to discover expert insights on leveraging biologics for optimal tissue regeneration.

(0:50) - To Heal Skin, Scientists Invent Living Bioelectronics Become a founding reader of our newsletter: http://read.thenextbyte.com/ As always, you can find these and other interesting & impactful engineering articles on Wevolver.com.

A best of episode where Russ interviews one of his bioengineering colleagues,  Fan Yang, about some of the fascinating work she's doing in the realm of tissue engineering. Hear more about the ways her lab is modeling human tissue to help develop a better understanding of how we might effectively replace damaged tissues and alleviate a number of health concerns.Episode Reference Links:Fan Yang's Stanford Profile: WebsiteFan Yang's Stanford Lab: WebsiteEp.174 Regenerating and Rejuvenating Human Tissues: Website / YouTube (original episode) Connect With Us:Episode Transcripts >>> The Future of Everything WebsiteConnect with Russ >>> Threads or Twitter/XConnect with School of Engineering >>> Twitter/XChapters:(00:00:00) IntroductionHost Russ Altman introduces guest Fan Yang, a bioengineer at Stanford.(00:03:15) The Basics of Tissue EngineeringThe purpose and significance of tissue engineering, emphasizing its role in addressing critical medical needs like late-stage arthritis.(00:04:23) Challenges in Tissue EngineeringTechnical hurdles in creating viable tissues for clinical use, such as integrating these tissues into the human body.(00:07:00) 3D Printing and In Situ PolymerizationTechnological advances in shaping tissues using 3D printing and the benefits of in situ polymerization to adapt to complex tissue shapes.(00:09:15) Specific Challenges with CartilageThe challenges specific to cartilage regeneration, explaining why it has been a difficult tissue to replicate and heal.(00:13:56) Micro Ribbon Based HydrogelsExplanation of micro ribbon based hydrogels, a new development aimed at improving tissue regeneration.(00:19:16) Cancer Research and Tissue EngineeringHow tissue engineering technologies are not only pivotal for therapeutic uses but also crucial for understanding diseases and aiding drug discovery.(00:24:38) Regulatory Challenges and CommercializationThe regulatory and commercialization challenges facing new medical technologies, including the need for industry partnerships and the role of the FDA(00:26:20) Conclusion Connect With Us:Episode Transcripts >>> The Future of Everything WebsiteConnect with Russ >>> Threads or Twitter/XConnect with School of Engineering >>> Twitter/X

Dr. Matt DiDuro shares with us a new technology that is sweeping the nation for reducing pain and inflammation. Dr. DiDuro brings over 24 years of Clinical experience to his patients, and currently runs two separate offices in Atlanta & Alpharetta. His practice is patient based with a focus on care for diabetics & neuropathic pain. Dr. DiDuro was one of the first chiropractors in New York that was invited to work in a rural medical setting. He was clinic director of chiropractic care at the Rushville Health Center from 2000-2005. His work helped deliver care to migrant workers and patients in remote areas of central New York. Dr. DiDuro has been privileged to teach at Life University. First, as a clinic doctor, and then as Co-Director of the Rehab department. He also served as advisor to the Chiropractic BioPhysics club, which focused on the ideal spinal model & ergonomics. While at Life University, he served on the HIPPA committee. Resources: softwavetrt.com Dr. DiDuro on Facebook drmattdiduro.com softwaveclinics.com Episode sponsor: The Cox 8 Table by Haven Medical  

To book a free session with me to discuss trying this technology, visit https://www.learntruehealth.com and click Work With Ashley James in the menu! Check out my new book! https://www.learntruehealth.com/addictedtowellness

Dr. Shiri Gur-Cohen is an Assistant Professor of Medicine in the Division of Regenerative Medicine at UC San Diego. Her lab studies epithelial stem cells throughout their lifetimes. She talks about lymphatics in the intestinal stem cell niche, 3D imaging techniques, and sharing her science with a wider audience.

To kick off 2024, we're bringing you an episode that's been one of our most popular. The timing is just right as many of us are headed into the new year thinking about how to live better. In this episode, Professor Helen Blau, a stem cell biologist, tells us all about how she's recruiting stem cells to regenerate youthful muscle in older people. We're thrilled to bring this episode out of the archives for another listen and renewed hope about possibilities ahead in the world of health.  Happy New Year from Russ and the team here at The Future of Everything. Contact Links:Episode Transcripts >>> The Future of Everything WebsiteConnect with Russ >>> Threads or Twitter/XConnect with School of Engineering >>> Twitter/XChapters:(00:00:00) Introduction & Importance of Muscles in AgingHost Russ Altman introduces the episode, the ways that muscles weakening with age affects us, and how guest, Professor Helen Blau's work with stem cells  is addressing this.(00:02:03) Regenerative Medicine & Stem CellsThe goals of regenerative medicine in enhancing the quality of life as people age. Overview of different types of stem cells and their potential.(00:04:28) Focus on Muscle: Sarcopenia and AgingEmphasizing the desire to age well, and the centrality of muscles in daily activities and how they atrophy with age.(00:07:44) Approaches to Combating Muscle AgingLack of available drugs addressing muscle wasting and potential research directions. Targeting stem cells and mature muscle fibers for rejuvenation.(00:09:09) Lab Discoveries and ChallengesDr.  Blau's lab experiments to identify and maintain functional stem cells, the breakthrough in bioengineering microenvironments & it's impact.(00:12:41) Stem Cell RejuvenationInsights into rejuvenating stem cell functions through cell therapy that lead to. (00:14:37) Inflammatory Pathways and Stem Cell ResponseDr Blau explains the importance of the wave of inflammation for stem cells, and the discoveries this lead to. (00:17:55) Broad-Scale Muscle RejuvenationExploring systemic alterations targeting inflammation pathways for global muscle regeneration. Identification of PGE-2 degrading enzyme and results of limiting this enzyme.(00:21:33) Human Trials, Challenges & Drug DevelopmentDiscussion on the prospects of translating findings to human treatments and developing an oral drug(00:24:42) Timeline and Clinical TrialsAnticipated timelines for the drug's availability for human trials and potential applications. Connect With Us:Episode Transcripts >>> The Future of Everything WebsiteConnect with Russ >>> Threads or Twitter/XConnect with School of Engineering >>> Twitter/X

In today's episode, we are diving deep into light therapy, specifically comparing Low-Level Laser Therapy (LLLT) and LED Light Therapy. We are clarifying the crucial distinctions between these two forms of therapy, focusing on the significance of various wavelengths of light and power densities in achieving therapeutic benefits. We explore studies that examine the effectiveness of LLLT and LED Light Therapy in contexts such as wrinkle reduction and lymphatic drainage, shedding light on the science behind these treatments and helping to clear up common misconceptions. Stay tuned! Topics: 1. Chromotherapy DIY - Establishing Foundational Knowledge about the Physics of Light - Difference Between LEDs and Lasers - Electroluminescence in LEDs - Omnidirectional Light Emission in LEDs - Low Coherence in LEDs - Population Inversion in Lasers - Stimulated Emission in Lasers - Highly Coherent and Amplified Beam in Lasers - Importance of Understanding Light Physics in Interpreting Scientific Studies - Risk of Misleading Information - Influx of Fake Chromotherapy Devices 2. Power and Power Density in Light Therapy - Radiant Power - Power Density or Irradiance - Significance in Light Therapy Devices - Determining Laser Performance - Evaluating Red Light Therapy LED Devices 3. Low-Level Laser Therapy (LLLT) - Properties of LLLT - Power Output (0.001-0.1 Watts) - Wavelength (300-10,600 nm) - Pulse Rate (0-5000 Hertz) - Intensity (0.01-10 W/cm²) and Dose (0.01-100 J/cm²) - Mechanism of LLLT - Photochemical Effect - Application in Tissue Regeneration, Inflammation Reduction, and Pain Relief 4. Studies on Light Therapy - Study on LLLT for Skin Rejuvenation - Parameters: 635 nm, 10mW power, 15-minute sessions, 6 weeks - Wrinkle Reduction and Collagen Upregulation - Study on LLLT Effects on Lymphatic Flow and Lymphedema - Parameters: 904 nm, 1.5 J/cm², 17-minute sessions, 9 sessions over 3 weeks - 90 ml Reduction in Upper-Limb Volume and Improved Quality of Life - Potential for Other Wavelengths of Light in Therapy (Yellow, Blue, Green, etc.) 5. Conclusion and Future Topics - Expanding the Understanding of Light Therapy - Exploring Therapeutic Uses of Lasers and LEDs in Dentistry, Cosmetics, Collagen Production, ATP Upregulation, and More Thanks for tuning in! Get Chloe's Book Today! "⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠75 Gut-Healing Strategies & Biohacks⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠" If you liked this episode, please leave a rating and review or share it to your stories over on Instagram. If you tag @synthesisofwellness, Chloe would love to personally thank you for listening! Follow Chloe on Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@synthesisofwellness⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Follow Chloe on TikTok @chloe_c_porter Visit ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠synthesisofwellness.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ to purchase products, subscribe to our mailing list, and more! Or visit ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠linktr.ee/synthesisofwellness⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ to see all of Chloe's links, schedule a BioPhotonic Scanner consult with Chloe, or support the show! Thanks again for tuning in! --- Support this podcast: https://podcasters.spotify.com/pod/show/chloe-porter6/support

Episode Description: We delve into the transformative world of biotechnology, with a special focus on the production of collagen and its implications for sustainability and wellness. Stephanie Michelsen, shares her insights on the fragility of supply chains revealed by the COVID pandemic and the biotech industry's response. We explore the ethical dimensions of lab-grown proteins and the potential for biotech to innovate in spaces that have remained unchanged for decades. Join us as we uncover the intersections of science, wellness, and the future of ethical production. Grow Everything brings to life the bioeconomy when hosts Karl Schmieder and Erum Azeez Khan share stories from the field and interview leaders and influencers in the space.  Life is a powerful force and it can be engineered. What are we creating? Learn more at www.messaginglab.com/groweverything Topics Covered: 00:00:00 - Embarking on a Journey: From Creativity to Biotech 00:02:52 - Unforgettable Halloween Adventures: From Pet Store to Trash Can 00:04:58 - Living Candy and Natural Dyes: Exploring the Future with Pro-Bites 00:07:33 - Culinary Delights: Experimenting with Natural Colors 00:09:26 - BioEU Awaits: Markets, Biotics, and Collagen in the Spotlight 00:12:20 - From Science to CEO: Stephanie's Journey in Danish Biotech 00:15:51 - Tracing the Collagen Supply Chain: Farms to Gelatin Extraction 00:17:53 - Revolutionizing Medical Collagen Production: Unveiling the Purity Puzzle Solution 00:23:06 - Engineering Better Proteins for a Sustainable Future 00:26:19 - Scaling Up in Biotech: Overcoming Challenges for Price Parity 00:31:12 - Stephanie Michelsen's Journey: From Animals to Cultivated Meat and Shellfish 00:36:25 - Future of Protein: Lab-Grown to Organic Evolution 00:38:54 - Personalized Human Collagen: Exploring Custom Medicine and Tissue Regeneration 00:40:18 - Eternal Youth and Reflections on Aging 00:45:52 - Post-COVID Era: Potential of Distributed Biological Manufacturing Episode Links: Jellatech (company site) Magic Valley (company site) Pearlita Foods (company site) Stephanie Michelsen (LinkedIn) Have a question or comment? Message us here: Text or Call (804) 505-5553 Instagram / TikTok / Twitter / LinkedIn / Youtube / GrowEverything website Email: groweverything@messaginglab.com Support here: Patreon Music by: Nihilore Production by: Amplafy Media --- Send in a voice message: https://podcasters.spotify.com/pod/show/messaginglab/message

Male pattern hair loss is something that over 80% of men will experience in their lifetime. Yet despite it being so widespread, the fundamentals of what actually causes it to occur, in the manner in which it occurs, still elude researchers to this day. According to a new paper, the secret may lie deep in our genetic past, with our embryonic origins. Dr. Claire Higgins, Reader in Tissue Regeneration from the Faculty of Engineering in the Department of Bioengineering of Imperial College London joins Jonathan to discuss.

Dr. Marco Quarta, Ph.D. is Co-Founder and CEO of Rubedo Life Sciences ( https://www.rubedolife.com/ ), a biopharmaceutical company developing a broad portfolio of innovative therapies engineered to target cells which drive chronic age-related diseases. The company's proprietary ALEMBIC™ drug discovery platform has engineered novel first-in-class small molecules designed to selectively target senescent cells, which play a key role in the progression of pulmonary, dermatological, oncological, neurodegenerative, fibrotic and other chronic disorders. Dr. Quarta received his doctorate degree in Biotechnology from the University of Bologna and a Ph.D. in Neuroscience from the University of Padua. He completed a post-doc in Aging and Stem cell Biology in the lab of Prof. Thomas Rando at Stanford University and continued his work at Stanford directing a research team at the Center for Tissue Regeneration, Repair, and Restoration at the VA Hospital in Palo Alto, CA. While there, he established a translational program in regenerative medicine. He has over 35 publications and patents in the field of aging, stem cells, regenerative medicine, and rejuvenation. Dr. Quarta also co-founded Wetware Concepts, Young European Biotech Network (YEBN), and Turn Biotechnology, and served as an executive board member of the European Federation of Biotechnologies. He currently sits on the advisory board of the California Institute for Regenerative Medicine (CIRM) Calpoly Bridge program, and the advisory board at the Center for Healthcare Innovation. He is a member of the Paul F Glenn Center for the Biology of Aging Studies at Stanford University, one of the most prestigious institutions supporting the science of aging. Dr. Quarta also serves as CEO and President for the Board of Directors of The Phaedon Institute ( https://www.phaedon.institute/ ), a think-tank organization that operates with the mission of supporting and enabling effective and sustainable growth in the field of aging and longevity sciences. Support the show

Dr. Ross Uhrich, DMD, MBA, is Program Manager, Advanced Research Projects Agency for Health ( ARPA-H - https://arpa-h.gov/people/ross-uhrich/ ), which is focused on advancing high-potential, high-impact biomedical and health research that cannot be readily accomplished through traditional research or commercial activity, accelerating better health outcomes targeting society's most challenging health problems. Under the ARPA-H portfolio, Dr. Uhrich is responsible for the recently launched Novel Innovations for Tissue Regeneration in Osteoarthritis ( NITRO - https://arpa-h.gov/engage/programs/nitro/ ) program which seeks to develop new ways of helping the human body repair its own joints, with the goal of revolutionizing treatment for osteoarthritis — a common and often very painful condition where bones and cartilage break down. Dr. Uhrich joined ARPA-H in March 2023 from Walter Reed National Military Medical Center (WRNMMC) and the Uniformed Services University of the Health Sciences, where he worked as a board-certified oral and maxillofacial surgeon and assistant professor of surgery. In addition to these roles, he spent 12 years with the U.S. Navy, finishing his tenure as a Lieutenant Commander. Throughout his career, Dr. Uhrich has cared for thousands of members of the U.S. Armed Forces at various healthcare facilities, including the USS Gerald R. Ford , Naval Health Clinic Quantico, and WRNMMC, and served as an oral and maxillofacial surgery consultant to Congress. He also treated patients at Charleston Area Medical Center, R Adams Cowley Shock Trauma Center, and Suburban Hospital. Dr. Uhrich holds a doctorate in dental medicine from the University of Pennsylvania, an MBA from the University of Virginia, and completed his surgical residency at WRNMMC. He also has a Bachelor of Science in Biomedical Engineering from Yale University. Support the show

Osteopore Ltd (ASX:OSX) Chairman Mark Leong speaks to Thomas Warner from Proactive London about the Australian-Singaporean medical technology company's pursuit of what he calls the "holy grail of tissue regeneration." Leong explains that aiming to commercialise products designed to enable natural bone healing across multiple therapeutic areas, including both hard and soft tissue. Initially focused on bone regeneration, Osteopore has received major regulatory approvals for their implants. However, their technology also holds promise for soft tissue regeneration, including shoulder rotator cuff tendon repair and cartilage regeneration. Looking ahead, the company aims to enter the "huge" Chinese market and is actively researching ways to accelerate tissue regeneration, potentially reducing healing time significantly. He says "In the next half a year or so you'll see us breaking some new ground into entering the Chinese market... and on the technology front we will be putting more effort into developing the soft tissue part because that's a whole new area of therapeutic treatment... we are chasing the holy grail of tissue regeneration which is to speed up tissue regeneration." #ProactiveInvestors #Osteopore #RegenerativeMedicine #TissueRegeneration #BioresorbableImplants #3DPrinting #MedicalInnovations #BoneRegeneration #SoftTissueRegeneration #HealthcareTechnology #MedicalResearch #MedicalAdvancements #ImplantTechnology #MedTech #MedicalBreakthroughs #Biotechnology #HealthcareInnovation #MedicalScience #Osteoporosis #Orthopedics #TissueEngineering #MedicalDevices #HealthTech #ScienceandTechnology #FutureofMedicine #MedicalDiscoveries #HealthcareRevolution #MedicineoftheFuture #InnovativeMedicine #MedicalTreatment #MedicalBreakthroughs #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

(3:00) - 3D printing with bacteria-loaded ink produces bone-like compositesThis episode was brought to you by Mouser, our favorite place to get electronics parts for any project, whether it be a hobby at home or a prototype for work. Click HERE to learn about how additive manufacturing is being leveraged in the medical industry from bone replacement to dental guides!

A new research paper was published on the cover of Aging (listed as "Aging (Albany NY)" by Medline/PubMed and "Aging-US" by Web of Science) Volume 15, Issue 3, entitled, “Immune-mediated platelet depletion augments Alzheimer's disease neuropathological hallmarks in APP-PS1 mice.” In Alzheimer's disease (AD), platelets become dysfunctional and might contribute to amyloid beta deposition. In a recent study, researchers Diana M. Bessa de Sousa, Ariane Benedetti, Barbara Altendorfer, Heike Mrowetz, Michael S. Unger, Katharina Schallmoser, Ludwig Aigner, and Kathrin Maria Kniewallner from Paracelsus Medical University and Austrian Cluster for Tissue Regeneration in Austria depleted platelets in one-year-old APP Swedish PS1 dE9 (APP-PS1) transgenic mice for five days, using intraperitoneal injections of an anti-CD42b antibody, and assessed changes in cerebral amyloidosis, plaque-associated neuritic dystrophy and gliosis. “The potential role of platelets in amyloid beta deposition led to the hypothesis that reducing platelet numbers might ameliorate AD pathology [30]. Here, we performed immune-mediated platelet depletion in APP-PS1 mice with an already fully developed amyloidosis and investigated its effects on classical hallmarks of AD: amyloid plaque pathology, plaque-associated neuritic dystrophy and gliosis.” In APP-PS1 female mice, platelet depletion shifted amyloid plaque size distribution towards bigger plaques and increased neuritic dystrophy in the hippocampus. In platelet-depleted females, plaque-associated Iba1+ microglia had lower amounts of fibrillar amyloid beta cargo and GFAP+ astrocytic processes showed a higher overlap with thioflavin S+ amyloid plaques. In contrast to the popular hypothesis that platelets foster plaque pathology, data from this study suggest that platelets might limit plaque growth and attenuate plaque-related neuritic dystrophy at advanced stages of amyloid plaque pathology in APP-PS1 female mice. Whether the changes in amyloid plaque pathology are due to a direct effect on amyloid beta deposition or are a consequence of altered glial function needs to be further elucidated. “In APP-PS1 females, acute thrombocytopenia aggravates AD neuropathology, suggesting that platelets might have a protective function in AD. However, the underlying molecular mechanisms by which platelets modulate amyloid plaque deposition remain elusive and need to be investigated in future experiments.” DOI: https://doi.org/10.18632/aging.204502 Corresponding Author: Kathrin Maria Kniewallner - kathrin.drerup@pmu.ac.at Keywords: Alzheimer's disease, platelets, amyloid-beta, microglia, astrocytes Sign up for free Altmetric alerts about this article: https://aging.altmetric.com/details/email_updates?id=10.18632%2Faging.204502 About Aging-US Launched in 2009, Aging-US publishes papers of general interest and biological significance in all fields of aging research and age-related diseases, including cancer—and now, with a special focus on COVID-19 vulnerability as an age-dependent syndrome. Topics in Aging-US go beyond traditional gerontology, including, but not limited to, cellular and molecular biology, human age-related diseases, pathology in model organisms, signal transduction pathways (e.g., p53, sirtuins, and PI-3K/AKT/mTOR, among others), and approaches to modulating these signaling pathways. Please visit our website at https://www.Aging-US.com​​ and connect with us: SoundCloud - https://soundcloud.com/Aging-Us Facebook - https://www.facebook.com/AgingUS/ Twitter - https://twitter.com/AgingJrnl Instagram - https://www.instagram.com/agingjrnl/ YouTube - https://www.youtube.com/@AgingJournal LinkedIn - https://www.linkedin.com/company/aging/ Pinterest - https://www.pinterest.com/AgingUS/ Media Contact 18009220957 MEDIA@IMPACTJOURNALS.COM

Support this podcast at — https://redcircle.com/hypnosis-and-relaxation-sound-therapy9715/donationsAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

Support this podcast at — https://redcircle.com/hypnosis-and-relaxation-sound-therapy9715/donationsAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

Dr. Steve Cohen, an internationally recognized plastic surgeon and the co-author of Regenerative Facial Surgery, joins Dr. Bass to look into the future of regenerative medicine within aesthetics.  Regenerative medicine focuses on enabling tissue regeneration in the body and restoration of normal function in cells, organs, or tissues to help the body regenerate or restore itself when there's an aging change or a disease.  Regenerative therapies not only  provide an aesthetic improvement in appearance, but actually alter the physiology of aging, slowing the process.  Though the aesthetic industry has already come a long way, we are just starting to see the impact of regenerative medicine in all fields of medicine. Hear about the research, past, current and future, related to regenerative medicine and find out what's out there to help now. About Steve Cohen, MD Dr. Steve Cohen is a San Diego-based and internationally recognized plastic surgeon, inventor, author, artist, and founder of FACES+. He currently specializes in cosmetic and craniofacial surgery. Links Learn more about Dr. Cohen's practice, FACES+   Read more about Dr. Steve Cohen About Dr. Lawrence Bass Innovator. Industry veteran. In-demand Park Avenue board certified plastic surgeon, Dr. Lawrence Bass is a true master of his craft, not only in the OR but as an industry pioneer in the development and evaluation of new aesthetic technologies. With locations in both Manhattan (on Park Avenue between 62nd and 63rd Streets) and in Great Neck, Long Island, Dr. Bass has earned his reputation as the plastic surgeon for the most discerning patients in NYC and beyond. To learn more, visit the Bass Plastic Surgery website or follow the team on Instagram @drbassnyc Subscribe to the Park Avenue Plastic Surgery Class newsletter to be notified of new episodes & receive exclusive invitations, offers, and information from Dr. Bass. 

This week on The Red Light Report, we have two more remarkable pieces of photobiomodulation research to cover and, to top it off, both are figuratively hot-off-the-press  —  being published only this past summer! You've heard me say it before, but I'll say it again... while the information may be on particular topics, the takeaways are far-reaching and can be applicable to virtually everyone.​ The first article covered has to do with the ability for red light therapy to improve the tissue regeneration capabilities of fibrin application. Who doesn't want more effective and efficient wound healing and tissue/organ healing? The second piece of research is especially interesting, as it has to do with red light therapy's impact on the brain. However, the article goes even deeper and analyzes the benefits of photobiomodulation temporally, meaning the therapeutic affects it has during wakefulness versus asleep. Needless to say, they have some interesting speculations as to how near-infrared light can impact the brain during sleep that has potentially profound implications for the glymphatic system. This new research continues to expand our awareness on some exciting, novel utilities of red light therapy that can positively impact our health.  As always, light up your health and enjoy this solosode! - Dr. Mike Belkowski discusses the following:  1:43 - Yoga red light therapy 2:49 - Therasage 5:41 - Improving regeneration in tissue via photobiomodulation 8:34 - Fibrin and photobiomodulation 9:10 - Management of the healing process via photobiomodulation 12:34 - Gold nanoparticles 13:31 - The effect of photobiomodulation during wakefulness and sleep 18:54 - Photobiomodulation influences functional activity 23:32 - Increasing mitochondrial activity 26:29 - Photobiomodulation and sleep 31:16 - Transcranial photobiomodulation 32:17 - Photobiomodulation mechanisms during sleep 35:52 - Mornings vs Day/ night for Increasing mitochondrial function and ATP levels 37:33 - Anti-inflammatory effects during sleep 43:40 - How to use near-infrared light while sleeping - Research articles: Application of Fibrin Associated with Photobiomodulation as a Promising Strategy to Improve Regeneration in Tissue Engineering: A Systematic Review   The effect of photobiomodulation on the brain during wakefulness and sleep - Check out the newest innovative device from BioLight... the Matrix! - Check out the Kindle version of Red Light Therapy Treatment Protocols eBook, 4th Edition - To learn more about red light therapy and shop for the highest-quality red light therapy products, visit https://www.biolight.shop - Stay up-to-date on social media: Instagram

Joining us in this episode is Vivek Kumar, a scientist, innovator, and entrepreneur. Vivek is ​​faculty at the New Jersey Institute of Technology (NJIT) and the Rutgers School of Dental Medicine, and is the Dhiraj Shah Faculty Fellow at the NJIT Albert Dorman Honors College. As the author of over 50 peer-reviewed articles and co-inventor of over a dozen patents and applications, Vivek contributes a great deal to both the scientific and entrepreneurial communities.  The Kumar Lab, which Vivek is the principal investigator of, researches the “genetic and neurobiological basis of complex behaviors that are important in psychiatric conditions such as addiction, ADHD, and depression using genomic, neural circuits, and computational tools.” Click play to hear Vivek discuss: Why his lab is investigating hydrogels for tissue and blood vessel regeneration.  What “dental pulp regeneration” is.  How to approach tissue regeneration.  Why wounds heal differently in different areas of the body.  Want to learn more about Vivek and his pursuits? Click here now! Episode also available on Apple Podcasts: http://apple.co/30PvU9C

Paul George, an assistant professor of neurology and neurological sciences at Stanford University, taps into the bioelectrical language of the injured brain to reawaken the healing potential of neural stem cells. Inspired by his patients, he looks for innovative strategies that may one day help patients recover from neurodegenerative diseases such as stroke. In this episode, Iris Kulbatski from The Scientist's Creative Services Team spoke with George to learn more about what being a scientist means to him. For more on this topic, please see "Stem Cell Engineering for Tissue Regeneration." Science Philosophy in a Flash is a series of mini podcasts produced by The Scientist's Creative Services team. With a focus on the people behind the science, this podcast highlights researchers' unique outlook on what motivates their pursuit of science and what it means to be a scientist.

This is part 2 of my stem cell journey! I will ask the challenging questions and answer those questions! Learn how to regenerate your body!! Don't miss this life changing episode!!

Rhodochrosite takes you deep within yourself to discover: Hidden barriers that you may be imposing upon yourselfCreate boundaries to secure your energyHeal soft tissue damageI share with you my personal experience with rhodochrosite and how this beautiful light shines awareness to  help you get to know yourself better,  heal and understand how soft tissue can become damaged within the body.Rhodochrosite has so much to offer, it surfaces compassion, love, understanding and broadens your ability to get to know yourself to a much deeper level. Rhodochrosite will aid mental stress by helping you put boundaries in place. We live in a 24/7 world and it can become overwhelming. Mental boundaries really do help us find peace, relax, take time out and not become overwhelmed by the expectation and demands that this lifestyle places upon us.Rhodochrosite helps us emotionally relax into feelings and sensations, drop barriers and recognise the truth that many emotions are simply a reaction to mental conditioning and incorrect thought patterns.If you are interested in Energy Medicine why not look at our video classes on Psychic Surgery https://www.britishacademyofcrystalhealing.co.uk/psychic-surgery-master-classes/

Dr. Morse talks about this video in this podcast: Tissue Regeneration video: https://drmorse.tv/video/tissue-regeneration/

This episode we will show you how there are fantastic non-drug interventions that will allow your body to regenerate!! Medications slow or staop metabolic processes, and the effects NOT "side effects" can alter how healthy your cells are! Don't miss this life saving and life changing episode!!

Valerie M. Weaver, Ph.D., is the Director of the Center for Bioengineering and Tissue Regeneration in the Department of Surgery. She is the editor for the special issues at Molecular Biology of the Cell on Forces on and Within Cells. --- Send in a voice message: https://anchor.fm/ascb-pathwayspodcast/message

In this episode, you will learn: • About James • How James started in the real estate investing business • James’ thoughts about stem cell therapy • The big learning experience that James had • James’ horizontal and vertical incomes • About James’ other business investments • What James does to stay fit and healthy • James’ life happiness index score • All about extreme accountability • James’ biggest business and personal goals for 2021 • The three past and future greatest hits in James’ life • Plus, so much more! James Aduna was born in the Philippines and moved to the United States at the age of 5. He grew up in New York City/New Jersey and currently lives in Los Angeles, California. James enjoys staying physically active and has competed in several Triathlons, Spartan Races and SealFit events. Today, he incorporates Meditation, Visualization, Box Breathing and Yoga in his daily routine. In his free time, he enjoys anything related to personal, professional, and financial growth. He also spends time with friends/family and fellow GoBro’s. James’ favorite books are Think & Grow Rich and Rich Dad Poor Dad. His favorite podcasts are Maxout with Ed Mylett and Impact Theory. James works in BioTech Sales in Tissue Regeneration. In addition, he invests in out of state SFH’s and Multi-family properties. Currently, he owns 15 doors in Memphis, TN and Little Rock, AR (just escrow in another 12 unit in Memphis). In addition, he is an LP in a 100+ Unit Apartment Syndication in Virginia and is working toward his goal of acquiring 60 doors in his portfolio. James decided to join the Tribe to surround himself with a community of like-minded men that will hold him accountable to his personal, professional, and real estate goals. He is excited to learn, grow and give back to the GoBundance Tribe!

An exciting step closer to a cure for diabetes starts with a bit of gastric tissue. Joe Zhou's lab works on tissue regeneration and repair and organ regeneration. In this podcast, he discusses a life-changing possibility alongside Richard's thoughtful questions. They take listeners across a new frontier of research, covering How insulin-producing beta cells have been destroyed in those who have type 1 diabetes, requiring them to inject manufactured insulin, How a process of converting beta cells from a patient's gastric tissue may solve numerous problems in other proposed solutions, and What challenges are still to be met, including fine tuning the introduction of the new cells into the pancreas.   Joe Zhou is a Professor of Regenerative Medicine at Cornell University. While the broad interest of his lab is tissue and organ regeneration in humans, he discusses an advancement in a specific cell generation, a cell important to the diabetes and insulin connection. Many important organs, he explains, don't have a robust ability to regenerate, including the pancreas. In type 1 diabetes, the insulin-producing beta cells have been attacked as if they were foreign invaders. Injecting insulin doesn't give these patients the fine tuning a working pancreas offers, and complications can be problematic and even severe. Dr. Zhou gives listeners a well-organized and listener-friendly review of different ways scientists have tried to reintroduce these cells in patients and sets up a helpful backdrop to his own research. He explains how his work may provide hope for both types of diabetes, addressing insulin resistance as well through introducing these healthy beta cells. His lab has been regenerating islet beta cells from human gastric tissue. The goal is to reintroduce those cells into the same patient, precluding rejection issues other transplant plans have caused. Basically, they are able to take adult gastric cells and treat them in a way to convert them directly to beta cells without having to return them to a pluripotent stage and all the complications that causes. They use powerful genes called master regulators to do this. "If we start with a select set of these master regulator beta cells," he says, "and put in a different tissue, we can directly convert them from one tissue to another tissue." He continues by explaining why this is especially true for gastric cells, how they grow the cells with an ex-vivo approach and introduce the genes, and which processes they hope to refine in the future. He addresses other challenges and successes as well. So listen in for some good news in the field of diabetes research. For more, see his lab's website: zhoulab.weill.cornell.edu. Available on Apple Podcasts: apple.co/2Os0myK

Carlos Leal, MDOrthopedic Surgeon from Bosque University in Bogotá, ColombiaPostdoctoral Fellow in Biomechanics and Research at Harvard UniversityFellow in Knee Surgery from NYU’s Hospital for Joint Diseases inNew York and the Aspen Valley Clinic in ColoradoInternational Leader In Regenerative Orthopedics, Stem Cells And Shockwave Medicine

Dr. Marcelo Freire is an Associate Professor of the Genomic Medicine and Infectious Disease Department at the J. Craig Venter Institute. He is also an Adjunct Professor of Infectious Diseases at the School of Medicine at the University of California, San Diego.  He received his clinical DDS from the University of Fluminense, Rio de Janeiro, Brazil. He later received his Ph.D. in Craniofacial Biology, focusing on Immune Engineering for Tissue Regeneration, from USC. He completed his Certificate in Periodontology and Doctor of Medical Sciences in Oral Biology from Harvard University. He completed postdoctoral research training in Immunology at the Forsyth Institute and was the award winner of the Balint Orban Memorial Award from the Academy of Periodontology.  Dr. Freire previously served as a faculty member at Harvard and the Forsyth Institute and is a diplomate of the American Board of Periodontology. As a dual-scientist and clinician, Dr. Freire's research focuses on the role of the human microbiome modulating chronic inflammation.  His current NIH-funded research program focuses on finding immune signals that are common to oral and systemic chronic inflammation present in diabetes, cardiovascular diseases, and periodontal diseases. By learning from complex host-microbial interactions, Freire's team is shedding light on novel diagnostics for chronic inflammation to novel therapeutics in tissue regeneration. Currently, Dr. Freire serves as the President of the Clinical and Translational Science Network of the International Association for the Dental Research and he is fully licensed to practice in the state of California. https://www.jcvi.org/about/marcelo-freirehttps://www.linkedin.com/in/drfreire/https://twitter.com/drmfreirehttps://www.instagram.com/marceloofreire--------------------------------www.theinternationaldentist.comLinkedIn: www.linkedin.com/in/drgabrielalagrecaFB & IG @theinternationaldentist 

Tissue regeneration and structural integrity are often overlooked in functional nutrition. That's why I'm thrilled to introduce you to Dr. Tyna Moore. Don’t miss today's episode where Dr. Tyna takes us through the importance of why tissues need support and what we can all do to encourage our clients to move, stretch and receive the foods that can make the biggest difference in the support of these cells. Click here to download the completed Matrix from this week’s episode To learn more about Dr, Tyna click here Click here to get your hands on a free copy of Dr. Tyna’s book ‘Pain Free and Strong’ Check out episode #104 where Dr. Tami Meraglia Maps Stem Cells on the 15-Minute Matrix Check out Episode #85 where Dr. David Brady maps Fibromyalgia on the 15-Minute Matrix For more information on dietary collagen check out the Functional Nutrition Alliance blog   Get 15-Minute Matrix podcast notifications delivered to your inbox!

In this episode, Dr. Cox continues his discussion on the influence of the vagus nerve in health and healing. He also shares a paper on mechanobiology, that is, how the cells of the body are constantly remodeling and adapting to their ever-changing mechanical environment. He concludes with a paper that goes beyond the 5 senses of sight, hearing, touch, smell, and taste to the newly described seventh sense. James M. Cox, DC, DACBR, FICC, Hon.D.Litt., FACO(H) Dr. Cox is the developer of Cox® Technic Flexion Distraction Manipulation and the proud participant in the on-going federal research projects involving the Keiser University, National University of Health Sciences, Palmer College of Chiropractic Research Center, Loyola Stritch School of Medicine, University of Illinois, University of Iowa, Auburn University, etc. He is a member of the postgraduate faculty of the National University of Health Sciences and has been privileged to speak throughout the world. Resources: About Dr. Cox curriculum vitae  More about Cox Technic Find a Back Doctor The Cox 8 Table by Haven Medical References: HHS Public Access Author manuscript Brain Behav Immun . Author manuscript; available in PMC 2019 January 04. Published in final edited form as: Brain Behav Immun . 2018 October ; 73: 441–449. doi:10.1016/j.bbi.2018.06.005. Joanna L. Ng, Mariana E. Kersh, Sharon Kilbreath and  M. Knothe Tate. Establishing the Basis for Mechanobiology-Based Physical Therapy Protocols to Potentiate Cellular Healing and Tissue Regeneration. Front.physiol.,06 June 2017 https://doi.org/10.3389/fphys.2017.00303 Kevin P. Cheng,  Sarah K. Brodnick, Stephan L. Blanz, Weifeng Zeng, Jack Kegel, Jane A. Pisaniello, Jared P. Ness, Erika Ross,  View ORCID ProfileEvan N. Nicolai, Megan L. Settell,  Is Vagus Nerve Stimulation Brain Washing? doi: https://doi.org/10.1101/733410 Cuoco J, Fnnie C, Cheriyan G: Hypothetical Link Between Osteopathic Suboccipital Decompression and Neuroimmunomodulation. J Neurol Neurosci. 2016, 7: S3. Christopher Bergland. Vagus Nerve Stimulation Dramatically Reduces Inflammation: Stimulating the vagus nerve reduces inflammation and the symptoms of arthritis. PSYCHOLOGY TODAY, posted July 6, 2016 Stanley Rosenberg: Accessing The Healing Power Of The Vagus Nerve. North Atlantic Books, Berkeley, CA Berrueta L, Muskaj I, Olenich S, Butler T, Badger GJ, Colas RA, Spite M, Serhan CN, Langevin HM. Stretching Impacts Inflammation Resolution in Connective Tissue. J Cell Physiol. 2015 Nov 20. doi: 10.1002/jcp.25263. [Epub ahead of print] Teodorczyk-Injeyan JA1, Triano JJ1, Injeyan HS2. Non-specific Low Back Pain: Inflammatory Profiles of Patients with Acute and Chronic Pain. Clin J Pain. 2019 Jul 5. doi: 10.1097/AJP.0000000000000745. [Epub ahead of print] Song XJ, Huang ZJ, Song WB, Song XS, Fuhr AF, Rosner AL, Ndtan H, Rupert RL. Attenuation Effect of Spinal Manipulation on Neuropathic and Postoperative Pain Through Activating Endogenous Anti-Inflammatory Cytokine Interleukin 10 in Rat Spinal Cord. J Manipulative Physiol Ther. 2016 Jan 30. pii: S0161-4754(15)00211-0. doi: 10.1016/j.jmpt.2015.12.004. Compiled by James M. Cox, DC, DACBR

Dr. Joy Wu is an Associate Professor of Medicine at Stanford University, and a a board-certified endocrinologist.  With both basic and translational research, her lab studies stem cell therapies for bone formation and the prevention of cancer metastases to bone, as well as the bone marrow hematopoietic niche.

Nearly half of the adult U.S. population suffers from some form of periodontal disease, which can result in the rapid destruction or slow reduction of bone, inflamed soft tissues, abscesses, and tooth loss. In the past, bone grafting—a procedure which is both time-consuming and expensive—was the only known method of getting bone back in the places where it should be. Now, a different technology is available: low-level laser therapy (LLLT). With the use of LLLT, bone regrowth can be obtained for less money, in less time, and provides more comfort to the patient than bone grafting and accelerated orthodontics techniques. But that's not all: the benefits of low-level laser therapy are wide-ranging, and have been shown to be effective in treating nearly any ailment which can improve with tissue regeneration. The technology has been used in both human and veterinary medicine, and shows great promise as a safe, affordable, and effective medical treatment. On today's episode, Dr. John Hendy joins the podcast to discuss all the ins and outs of LLLT, including how he has incorporated it into his work with patients. By tuning in, you will learn: What it feels like to receive LLLT How LLLT can direct nerves away from tooth decay, thereby potentially preventing the need for root canal procedures How the combination of high-energy and low-level energy laser therapy work to combat even the most severe cases of periodontal disease

It’s estimated that at least 500,000 people in the U.S. are living with pulmonary fibrosis,” says David Lagares, PhD, director of the matrix and mechanobiology program at MGH Fibrosis Research Center. His lab is investigating tissue regeneration and fibrosis after lung injury and developing therapeutic strategies to promote the regeneration of chronically damaged organs.

Host Ernie Hood interviews Dr. Kenneth Poss from Duke University

You probably didn't realize that you're likely wearing a material that can serve as the foundation of biomaterials used for a variety of functions, including drug delivery, tissue regeneration, and in vitro disease modelling. That's right, Jeannine Coburn, PhD is an assistant professor at Worcester Polytechnic Institute who is altering silk fibroin—a material found in most articles of clothing—to create unique properties that could have a number of biomedical applications. In addition to silk fibroin, Dr. Coburn and her team are working with chondroitin sulfate and bacteria and plant-derived cellulose for testing methods of tissue regeneration and studying disease processes that occur in the body. One of the main focuses of Dr. Coburn's lab is on intratumoral drug delivery—the delivery of drugs locally inside cancerous tumors rather than systemically as conventionally done today. In order to do this, they are considering different drug delivery modifications that will allow the drugs to act more or less with the material in which they are enclosed, thereby allowing for control over the rate at which the drugs are released into tumors. In this way, the drug delivery system would mimic that of conventional practices while minimizing the many negative effects of chemotherapy on the body's organs. Dr. Coburn discusses the main challenge of this pursuit—namely the problem of rejection by the body. In other words, how can they prevent the body from encapsulating and attacking the drug that it identifies as a foreign body? Answering this question leads to an informative and intriguing conversation about the body's mechanism of immune response, inflammatory responses, and how cancer cells shut off their immune recognition and how that can be modelled in vitro for the study of immunotherapy drugs used to treat cancer. Interested in learning more? Tune in for the full conversation and don't hesitate to contact Dr. Coburn directly by email at jmcoburn@wpi.edu.

Vince Giuliano from Aging-Sciences.com explains the new paradigm of how cells can revert to their previous sell state through epigenetics and inflammation for tissue regeneration. We also discuss the potential downside of senolytics and how senescent cells can indirectly help promote cellular regeneration, as well as his opinion on human connection and strong relationships.

Vince Giuliano from Aging-Sciences.com explains the new paradigm of how cells can revert to their previous sell state through epigenetics and inflammation for tissue regeneration. We also discuss the potential downside of senolytics and how senescent cells can indirectly help promote cellular regeneration, as well as his opinion on human connection and strong relationships.

Laurie A. Boyer, PhD, Associate Professor of Biology and Biological Engineering at MIT, discusses her work studying cell fate and cardiac regeneration. She shares how her lab is dissecting the gene regulatory mechanisms that control lineage commitment during heart development and congenital heart defects and applying this knowledge toward engineering cardiac tissues. Series: "Stem Cell Channel" [Health and Medicine] [Education] [Professional Medical Education] [Show ID: 33775]

Laurie A. Boyer, PhD, Associate Professor of Biology and Biological Engineering at MIT, discusses her work studying cell fate and cardiac regeneration. She shares how her lab is dissecting the gene regulatory mechanisms that control lineage commitment during heart development and congenital heart defects and applying this knowledge toward engineering cardiac tissues. Series: "Stem Cell Channel" [Health and Medicine] [Education] [Professional Medical Education] [Show ID: 33775]

Laurie A. Boyer, PhD, Associate Professor of Biology and Biological Engineering at MIT, discusses her work studying cell fate and cardiac regeneration. She shares how her lab is dissecting the gene regulatory mechanisms that control lineage commitment during heart development and congenital heart defects and applying this knowledge toward engineering cardiac tissues. Series: "Stem Cell Channel" [Health and Medicine] [Education] [Professional Medical Education] [Show ID: 33775]

Laurie A. Boyer, PhD, Associate Professor of Biology and Biological Engineering at MIT, discusses her work studying cell fate and cardiac regeneration. She shares how her lab is dissecting the gene regulatory mechanisms that control lineage commitment during heart development and congenital heart defects and applying this knowledge toward engineering cardiac tissues. Series: "Women in Science" [Health and Medicine] [Education] [Professional Medical Education] [Show ID: 33775]

Laurie A. Boyer, PhD, Associate Professor of Biology and Biological Engineering at MIT, discusses her work studying cell fate and cardiac regeneration. She shares how her lab is dissecting the gene regulatory mechanisms that control lineage commitment during heart development and congenital heart defects and applying this knowledge toward engineering cardiac tissues. Series: "Women in Science" [Health and Medicine] [Education] [Professional Medical Education] [Show ID: 33775]

Laurie A. Boyer, PhD, Associate Professor of Biology and Biological Engineering at MIT, discusses her work studying cell fate and cardiac regeneration. She shares how her lab is dissecting the gene regulatory mechanisms that control lineage commitment during heart development and congenital heart defects and applying this knowledge toward engineering cardiac tissues. Series: "Stem Cell Channel" [Health and Medicine] [Education] [Professional Medical Education] [Show ID: 33775]

Laurie A. Boyer, PhD, Associate Professor of Biology and Biological Engineering at MIT, discusses her work studying cell fate and cardiac regeneration. She shares how her lab is dissecting the gene regulatory mechanisms that control lineage commitment during heart development and congenital heart defects and applying this knowledge toward engineering cardiac tissues. Series: "Stem Cell Channel" [Health and Medicine] [Education] [Professional Medical Education] [Show ID: 33775]

Laurie A. Boyer, PhD, Associate Professor of Biology and Biological Engineering at MIT, discusses her work studying cell fate and cardiac regeneration. She shares how her lab is dissecting the gene regulatory mechanisms that control lineage commitment during heart development and congenital heart defects and applying this knowledge toward engineering cardiac tissues. Series: "Stem Cell Channel" [Health and Medicine] [Education] [Professional Medical Education] [Show ID: 33775]

Laurie A. Boyer, PhD, Associate Professor of Biology and Biological Engineering at MIT, discusses her work studying cell fate and cardiac regeneration. She shares how her lab is dissecting the gene regulatory mechanisms that control lineage commitment during heart development and congenital heart defects and applying this knowledge toward engineering cardiac tissues. Series: "Stem Cell Channel" [Health and Medicine] [Education] [Professional Medical Education] [Show ID: 33775]

Laurie A. Boyer, PhD, Associate Professor of Biology and Biological Engineering at MIT, discusses her work studying cell fate and cardiac regeneration. She shares how her lab is dissecting the gene regulatory mechanisms that control lineage commitment during heart development and congenital heart defects and applying this knowledge toward engineering cardiac tissues. Series: "Stem Cell Channel" [Health and Medicine] [Education] [Professional Medical Education] [Show ID: 33775]

Bioquark Inc. & Tissue Regeneration with Ira S. Pastor Bioquark Inc. is focused on the development of novel biologics that have the ability to naturally modify the regulatory state of human tissues and organs, with the goal of curing a range of chronic degenerative diseases, as well as effecting complex regeneration. The biologic regulatory states of our cells, tissues, and organs represent the central control processes behind our health (as well as our unfortunate transition towards disease, degeneration, and aging). Merging 21st-century knowledge of regenerative biology, evolutionary genomics, and bio-cybernetics, Bioquark’s core program focuses on developing a novel class of substances termed combinatorial biologics, which take a unique approach to reversing underlying disease, degeneration or aging processes, as opposed to only affecting the symptoms of such conditions. Ira Pastor, Chief Executive Officer More than 30 years of experience across multiple sectors of the pharmaceutical industry including pharmaceutical commercialization, biotech drug development, managed care, distribution, OTC, and retail; Served as VP, Business Development for drug development company Phytomedics Inc., raising $40 million of private equity, consummating over $50 million of licensing deals, and bringing lead drug candidate from discovery stage to Phase III development. For more information visit: http://www.bioquark.com/ ************************************************* For more information about BITEradio products and services visit: http://www.biteradio.me/index.htm

ASK A SCIENTIST @ IRA PASTOR Ira Pastor – Chief Executive Officer. Over 30 years of experience across multiple sectors of the pharmaceutical industry including pharmaceutical commercialization, biotech drug development, managed care, distribution, OTC, and retail; Served as VP, Business Development for drug development company Phytomedics Inc.  BioQuark's Ira Pastor: Meet the Man Whose Biotech Company Is https://nextshark.com/ira-pastor-bioquark-interview/ May 5, 2016 - Meet Ira Pastor, the CEO of BioQuark, director of the ReAnima project, and a man who may soon bring the dead back to life. In the coming months, Pastor's team of doctors will attempt to bring patients back from what science considers to be an irreversible death.

CEO in 10 with Ira Pastor hosted by Rick Tocquigny.   an article from the recent edition of Worth Magazine (25 Strategies for Living Longer) discussing Bioquark Inc. (www.bioquark.com) - #16 - "Pay Attention to Developments in Tissue Regeneration" - http://www.worth.com/25-ways-to-live-longer/   - a link to a recent podcast from The Longevity and Biohacking Show - http://hartmanmedia.com/ls-101-regenerating-cells-body-parts-path-eternal-life-bioquarks-ira-pastor/   - an article from U.S. News & World Report referencing our work in synthetic biology, diabetes, and induced pancreatic regeneration and repair: http://health.usnews.com/health-care/patient-advice/articles/2017-06-29/how-could-synthetic-biology-help-people-with-diabetes   - some information on our on-going anti-aging / longevity research with our partners in Russia and the Eurasian region: http://www.prweb.com/releases/2017/06/prweb14471477.htm   Lastly, here is a new write-up that you may find of interest:   "Harnessing Nature for Regeneration, Disease Reversion, and Rejuvenation" - Health Triangle Magazine   https://issuu.com/healthtrianglemagazine/docs/htm_49_uniflip  

Host: Brian P. McDonough, MD, FAAFP Dr. Brian McDonough welcomes Lee Buckler, Director, Chief Executive Officer and President of RepliCel Life Sciences based in Vancouver, BC. Mr. Buckler and his colleagues are tackling a mix of medical and cosmetic issues that include hair regeneration, repair of painful and debilitating tendon injuries and rejuvenation of damaged skin.

Tony Wyss-Coray is a professor of Neurology and Neurological Sciences at Stanford University, the Co-Director of the Stanford Alzheimer’s Disease Research Center, and the Associate Director of the Center for Tissue Regeneration, Repair and Restoration at the Palo Alto VA. In this talk he talks about blood borne factors from young mice or humans are sufficient to slow aspects of brain aging and improve cognitive function in old mice, and vice versa, factors from old mice are detrimental for young mice and impair cognition.

  Become empowered by gaining control of your mind and health!! Join Dr. John Bergman as he shares the secrets to living a healthy lifestyle. Healthy and Wealthy!! This week we will share the latest health information on how to Reverse Disease and Tissue Regeneration through training your Mind. You deserve the Truth ! We will give you tools to create a healthy body, clear mind, and uplifted spirit. That is true wealth. Join us for a half hour of restoration. We will pump you up, feed your brain, and put you back on the road to a wealthy and healthy lifestyle. Yes, It is a lifestyle.  

Is it possible to regenerate human limbs and other tissues in the lab? Major breakthroughs in understanding tissue regeneration come from a planarian named Schmidtea. Come learn about this special flat worm and the science of tissue regeneration.

Dr. Jill Helms, Associate Professor of Surgery at the Stanford School of Medicine, discusses developments in stem cell research and the future of regenerative medicine. (October 6, 2009)

I'm sure everyone has stopped to admire the impressive sight of a stag during the rut. But what is the biology underlying the phenomenon of annual antler growth and shedding? Professor Jo Price explains and describes her research into the mechanisms of this unusual example of mammalian tissue regeneration.